INMUNE BIO INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
INMUNE BIO INC. (INMB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 22.00 thousand shares for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2025-08-07
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2024-12-31 was 117.50K shares.
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 149.00K shares, a 1330.35% increase from fiscal 2023.
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 10.42K shares, a 86.03% decline from fiscal 2022.
- INMUNE BIO INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 74.58K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2025-06-30 | 22.00K shares 10-Q · filed 2025-08-07 | |||
| 2024-12-31 | 117.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 149.00K shares 10-K · filed 2025-03-27 | ||
| 2024-09-30 | 31.50K shares 10-Q · filed 2024-10-31 | |||
| 2023-12-31 | 10.42K shares 10-K · filed 2025-03-27 | |||
| 2022-12-31 | 74.58K shares 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |